AGGF1和HIF-1α及VEGF表達與食管鱗癌放療預(yù)后相關(guān)性研究
本文選題:食管鱗癌 切入點:AGGF1 出處:《新疆醫(yī)科大學(xué)》2017年碩士論文
【摘要】:目的:食管鱗狀細胞癌是一種比較常見的上消化道惡性腫瘤,放射治療是食管鱗癌的主要治療方法之一。本研究旨在探討食管鱗癌組織中AGGF1和HIF-1α及VEGF的表達情況,及其與食管鱗癌的臨床病理特征、放療療效及預(yù)后的關(guān)系。方法:該研究采用免疫組化SP法,檢測新疆醫(yī)科大學(xué)附屬腫瘤醫(yī)院胸腹放療科2011-01-01—2015-01-01收治的79例食管鱗癌和20例正常食管組織中AGGF1、HIF-1α和VEGF的表達,結(jié)合臨床病理特征和隨訪資料進行相關(guān)研究分析。結(jié)果:79例食管鱗癌中AGGF1(χ2=18.975,P0.001)、HIF-1α(χ2=26.884,P0.001)和VEGF(χ2=22.702,P0.001)的表達顯著高于20例正常食管組織中的表達。食管鱗癌中AGGF1(χ2=8.134,P=0.004)和VEGF(χ2=5.175,P=0.023)的表達與淋巴結(jié)轉(zhuǎn)移密切相關(guān);HIF-1α的表達與臨床分期(χ2=5.882,P=0.015)、淋巴結(jié)轉(zhuǎn)移(χ2=7.712,P=0.005)和浸潤深度(χ2=5.538,P=0.019)密切相關(guān)。食管鱗癌中VEGF和HIF-1α的表達呈正相關(guān)(r=0.333,P=0.003);AGGF1和VEGF的表達呈正相關(guān)(r=0.790,P0.001)。放療近期療效與HIF-1α的表達呈負相關(guān)(r=-0.246,P=0.029)。AGGF1(P=0.170)和VEGF(P=0.229)陽性表達組OS短于陰性組;HIF-1α陽性表達組OS顯著短于陰性組(P=0.013)。Cox多因素回歸分析顯示,HIF-1α陽性表達(P=0.002)、浸潤深度(P=0.005)和臨床分期(P0.001)是食管鱗癌患者生存預(yù)后的影響因素。結(jié)論:AGGF1,HIF-1α及VEGF在食管鱗癌組織中高表達,并與食管鱗癌臨床病理特征密切相關(guān),三者高表達可能對食管鱗癌的放療療效和生存預(yù)后有影響,可為提高食管鱗癌的放療效果和改善生存預(yù)后提供新的思路和方法。
[Abstract]:Objective: esophageal squamous cell carcinoma is a common malignant tumor of upper digestive tract, radiotherapy is one of the main treatment methods of esophageal squamous cell carcinoma.The purpose of this study was to investigate the expression of AGGF1, HIF-1 偽 and VEGF in esophageal squamous cell carcinoma and its relationship with the clinicopathological features, radiotherapy efficacy and prognosis of esophageal squamous cell carcinoma.Methods: immunohistochemical SP method was used to detect the expression of AGGF1HIF-1 偽 and VEGF in 79 cases of esophageal squamous cell carcinoma and 20 cases of normal esophageal tissues treated in Department of chest and abdominal radiotherapy, affiliated Cancer Hospital of Xinjiang Medical University, 2011-01-01-2015-01-01.Combined with clinicopathological features and follow-up data to carry out related research and analysis.Results the expression of AGGF-1 偽 and VEGF in 79 cases of esophageal squamous cell carcinoma were significantly higher than those in 20 normal esophageal tissues.There was a positive correlation between the expression of VEGF and HIF-1 偽 in esophageal squamous cell carcinoma.It is a prognostic factor of esophageal squamous cell carcinoma.Conclusion the high expression of HIF-1 偽 and VEGF in esophageal squamous cell carcinoma is closely related to the clinicopathological features of esophageal squamous cell carcinoma. The overexpression of these three proteins may have an effect on the radiotherapy efficacy and survival prognosis of esophageal squamous cell carcinoma.It can provide new ideas and methods for improving radiotherapy effect and survival prognosis of esophageal squamous cell carcinoma.
【學(xué)位授予單位】:新疆醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R735.1
【參考文獻】
相關(guān)期刊論文 前10條
1 曾敏;徐利強;嚴(yán)會志;原野男;伍鍋;;血管內(nèi)皮生長因子(VEGF)在非小細胞肺癌中的表達及其與臨床病理特征的相關(guān)性[J];現(xiàn)代腫瘤醫(yī)學(xué);2016年21期
2 王遠;徐放;解志娟;高志安;;HIF-1α和E-cadherin蛋白在大腸腺癌中的表達及臨床意義[J];中國老年學(xué)雜志;2016年13期
3 楊澤妹;黃守國;;人G補綴FHA域血管生成因子1在宮頸癌組織中的表達及其臨床意義[J];中國現(xiàn)代醫(yī)學(xué)雜志;2016年03期
4 袁慧敏;;缺氧誘導(dǎo)因子-1及血管內(nèi)皮生長因子-C在食管鱗癌中的表達及意義[J];現(xiàn)代實用醫(yī)學(xué);2015年05期
5 劉石萍;董媛媛;孔衛(wèi)平;史延卿;王軍民;王海利;徐超;張靜;田云霄;;MIF、MMP-9和VEGF在食管癌組織中的表達及臨床意義[J];大連醫(yī)科大學(xué)學(xué)報;2015年02期
6 馬志元;楊哲鋒;畢文忠;;AGGF1在肝癌中的表達及與預(yù)后的關(guān)系[J];現(xiàn)代腫瘤醫(yī)學(xué);2015年09期
7 劉建平;張永恒;付茂勇;;VEGF-C與食管鱗癌淋巴管生成的研究進展[J];現(xiàn)代腫瘤醫(yī)學(xué);2015年09期
8 史鴻云;李志剛;劉妙玲;祝淑釵;薛桂花;李延紅;;沉默食管癌ECA109細胞H2AX基因?qū)β闶笠浦擦龇派涿舾行缘挠绊慬J];中華放射醫(yī)學(xué)與防護雜志;2014年11期
9 閻景紅;艾尼瓦爾·艾木都拉;郝潔;楊玉剛;包永星;;2009-2012年新疆腫瘤監(jiān)測點新源縣惡性腫瘤發(fā)病分析[J];新疆醫(yī)科大學(xué)學(xué)報;2014年06期
10 Kyle J Napier;Mary Scheerer;Subhasis Misra;;Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities[J];World Journal of Gastrointestinal Oncology;2014年05期
,本文編號:1724432
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1724432.html